Alex Cranberg is an active early-stage biotech investor with strong ties to the Texas and Houston biotech ecosystem. Alex is the Chairman and Founder of the Board of Aspect Management Corporation, which manages the Aspect family of companies. Aspect is a global enterprise, which has invested over $1 billion in energy exploration and production activities. Alex is also an active biotech investor in several early-stage companies. He served on The University of Texas System Board of Regents and also on the Board of the Texas Medical Center. He holds an M.B.A. from Stanford University and a degree in petroleum engineering from University of Texas at Austin.